| CYC-116 |
|
| (CAS 693228-63-6) |
 |
| Description： |
Biological Activity of CYC116: CYC116 is an orally bioavailable small molecule Aurora kinase/VEGFR2 inhibitor with antineoplastic activity. CYC116 inhibits Aurora kinases A and B and VEGFR2, resulting in disruption of the cell cycle, rapid cell death, and the inhibition of angiogenesis. CYC116 has a unique target profile involving both cell cycle and angiogenesis inhibition mechanisms. In preclinical studies, it demonstrated antitumor activity in both solid tumors and hematological cancers.
|
| Product No. |
KT00319 |
| Product Name |
CYC-116 |
| Synonyms |
|
| Formal Name |
|
| CAS Number |
693228-63-6 |
| Molecular Formula |
C18H20N6OS |
| Formula Weight |
368.46 |
| Formulation |
A crystalline solid |
| Purity |
98%min |
| Stability |
2 years |
| Storage |
-20°C |
| Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
| Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
| Price & Availability |
In Stock. Price Negotiated. |
|
| Related Products： |
Alisertib
AMG 900
AT9283
Aurora A inhibitor I
AZD1152
CCT 137690
CCT129202
ENMD-2076
GSK-1070916
JNJ-7706621
MK-5108
MLN8054
|
|
